Quantum-Si Incorporated reported a net loss of $21.7 million for Q1 2026, with loss per share at $0.10. Total assets declined to $213.3 million from $245.6 million at year-end 2025, while stockholders’ equity fell to $200.7 million from $220.2 million. The company completed a direct equity offering during the quarter, issuing 15.625 million shares and raising $46.8 million net of fees. Weighted-average shares outstanding reached 216.5 million. Research and development expenses remained substantial as the company continues investing in product development and commercialization, though no new material legal commitments or contingencies were reported.
In-Depth:
Key Highlights from the Q1 2026 Report
- Total Assets: \$213.3 million as of March 31, 2026, down from \$245.6 million at December 31, 2025.
- Total Stockholders’ Equity: \$200.7 million as of March 31, 2026, down from \$220.2 million at December 31, 2025.
- Net Loss: \$(21.7) million for the three months concludeed March 31, 2026, compared to prior periods.
- Net Loss per Share (Basic and Diluted): \$(0.10) for Q1 2026.
- Weighted-Average Shares Outstanding: 216.5 million for Q1 2026.
- Significant Capital Raise: The company completed a direct equity offering, issuing 15,625,000 shares and raising \$46.8 million (net of fees and issuance costs) during Q1 2026.
- Stock-Based Compensation: The company continued to recognize stock-based compensation expenses as part of its ongoing employee incentive programs.
- R&D Expenses: Research and development expenses remained a major part of the company’s cost structure, reflecting continued investment in product development and commercialization efforts.
- No Commitments or Contingencies Reported: The company did not report any new material legal commitments or contingencies for the quarter.
Details and Analysis
Financial Position and Liquidity
Quantum-Si concludeed the quarter with \$213.3 million in total assets, a notable decrease from \$245.6 million at the conclude of 2025. The primary driver of this decline was the company’s net loss for the quarter, partially offset by a successful equity capital raise.
The direct equity offering, which brought in \$46.8 million, substantially bolstered the company’s liquidity. This capital raise may assist to extconclude the company’s runway and fund ongoing research & development and commercialization activities.
Profitability and Losses
The company reported a net loss of \$(21.7) million, continuing its trconclude of operating losses due to high R&D and SG&A expenses as it pursues commercialization of its product portfolio. The loss per share of \$(0.10) is a key figure for investors, indicating dilution and ongoing negative earnings.
Weighted-average shares outstanding rose to 216.5 million, largely due to the new shares issued in the equity offering, which could have a dilutive effect on existing shareholders.
Operating Expenses
- Research and Development: R&D expenses remain significant, reflecting the strategic focus on product innovation and development. This is a positive for long-term growth but contributes to ongoing losses in the near term.
- Stock-Based Compensation: The company continues to apply equity compensation as a key part of its employee incentive and retention strategy, resulting in ongoing non-cash expenses in the financial statements.
Comprehensive Loss and Equity Changes
The company’s other comprehensive loss for the quarter was impacted by unrealized losses on marketable securities, but this was a minor component compared to operating losses. Total stockholders’ equity decreased by approximately \$19.5 million over the quarter, reflecting the net loss, partially offset by the capital raise.
Key Investor Considerations
- Capital Raise and Dilution: The \$46.8 million direct equity offering is a significant event, providing necessaryed liquidity but increasing the share count and diluting existing shareholders. Investors should assess the trade-off between improved liquidity and dilution.
- Ongoing Losses and Cash Burn: The continued net losses underscore the company’s reliance on external financing to sustain operations until it can generate positive operating cash flows.
- R&D Commitment: Ongoing investments in R&D signal the company’s intent to develop and commercialize new products, which could drive future growth if successful.
- Market and Regulatory Risks: The company’s forward-seeing statements highlight risks from macroeconomic conditions, regulatory alters, and the ability to maintain its Nasdaq listing.
- No New Legal or Regulatory Issues: The absence of new material commitments or contingencies in the quarter is a positive, suggesting no new legal or regulatory headwinds have emerged.
Outsee and Potential Share Price Impact
The successful capital raise is the most notable, potentially price-sensitive event this quarter. It strengthens Quantum-Si’s balance sheet and should be viewed as a positive for the company’s ability to fund operations and pursue growth initiatives. However, the dilution from the new shares may weigh on the stock price in the short term.
Investors will continue to monitor Quantum-Si’s progress in product commercialization, R&D productivity, and its path toward profitability. Persistent operating losses and the necessary for further capital raises remain key risks, while any positive developments in commercial traction or cost discipline could provide upside.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own research or consult with a qualified financial advisor before creating any investment decisions. The information is based on Quantum-Si Incorporated’s Q1 2026 financial report and may contain forward-seeing statements subject to risks and uncertainties.
View Quantum-Si Inc Historical chart here
